Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Bardavon bid to revolutionize workers’ compensation just got a $15 million boost
Timing is everything, said Matt Condon, announcing this week $15 million in new financing to help scale his Overland Park-based company’s reach into markets from coast to coast. “Our national expansion is coming at a time when employers across the country are recognizing that they must play a lead role in the transformation of health…
KCultivator Q&A: Mother inspires Davin Gordon to remove ‘can’t’ from the conversation
Editor’s note: KCultivators is a lighthearted profile series to highlight people who are meaningfully enriching Kansas City’s entrepreneurial ecosystem. The KCultivator Series is sponsored by WeWork Corrigan Station, a modern twist on Kansas City office space. Kansas City’s future depends on whether the business community invests in homegrown talent, Davin Gordon said. “It doesn’t have…
AltCap winner launching its first Rightfully Sewn-label little black dress at TEDxKC Women
Winning $10,000 in this week’s AltCap Your Biz Competition will help Rightfully Sewn expand, Jennifer Lapka said — a move coming on the heels of the social endeavor releasing the first dress under its own label to support the Crossroads-based seamstress training program. “It’s a stylish, well-made LBD (little black dress) that women can wear…
On the TechWalk runway: This is what real KC Women in Tech look like
Tech careers are available to everyone, said Ventura Rangel. Kansas City Women in Technology, a nonprofit dedicated to growing the number of women in technology careers, played host to its second annual TechWalk fashion show, showcasing female tech professionals on the runway, said Rangel, event director for KCWiT. The goal is to inspire young girls…